Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome

A. Rennings, P. Meijer, D. van Uden, C. Tack, P. Smits, O. Boerman, W. Oyen and G. Rongen

Department of Pharmacology-Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Evidence Based Practice and Institute for Genetic and Metabolic Disease, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Apr, 2010